Back to Search Start Over

Plasma lipidome differences in patients with and without significant carotid plaque.

Authors :
Malý M
Kučerka O
Bechyňská K
Kočí K
Mandys V
Hajšlová J
Kosek V
Source :
Vascular pharmacology [Vascul Pharmacol] 2024 Jun; Vol. 155, pp. 107377. Date of Electronic Publication: 2024 May 03.
Publication Year :
2024

Abstract

Background: Atherosclerosis is a major cause of ischemic stroke, and early detection of advanced atherosclerosis in the carotid artery is important for reducing morbidity and mortality. What is even more important is not only detection of atherosclerosis but early determination whether the patients are at high risk of an event with adverse effects as the size of the plaque does not necessarily reflect its potential to trigger such events.<br />Aim: We studied whether plasma lipidomics profile can be used as a diagnostic tool for stratification of stable or unstable plaques without the need of removing the carotid plaque.<br />Methods: This study used liquid chromatography high-resolution tandem mass spectrometry lipidomics to characterize lipid profiles in patients' plasma and found that patients with significant and complicated (vulnerable) atherosclerotic plaque had distinct lipid profiles compared to those with insignificant plaques.<br />Results: The lipid classes that were most predictive of vulnerable plaque were lysophosphoethanolamines, fatty acyl esters of hydroxy fatty acids, free fatty acids, plasmalogens, and triacylglycerols. Most of these compounds were found decreased in plasma of patients with unstable plaques which enabled sufficient performance of a statistical model used for patient stratification.<br />Conclusions: Plasma lipidomes measured by liquid chromatography-mass spectrometry show differences in patients with stable and unstable carotid plaques, therefore these compounds could potentially be used as biomarkers for unstable plaque in future clinical diagnosis.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-3649
Volume :
155
Database :
MEDLINE
Journal :
Vascular pharmacology
Publication Type :
Academic Journal
Accession number :
38705432
Full Text :
https://doi.org/10.1016/j.vph.2024.107377